Clinical Trials Logo

Clinical Trial Summary

The proposed study will determine whether G6PD-deficient RBCs store differently than normal RBCs under standard blood banking conditions. The investigators plan to screen a large number of healthy male volunteers for G6PD deficiency in order to identify 10 G6PD deficient and 30 matched normal individuals using a blood sample obtained from a finger-stick. The identified individuals will then be asked to donate a unit of blood that will be stored for up to 42 days and various tests will be performed on these units during storage. At 6 weeks of storage a portion of the unit will be radioactively labeled and re-infused into the volunteer. Blood samples will be drawn before, during, and after the infusion to measure how well or poorly the red blood cells survive after transfusion.


Clinical Trial Description

Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common enzyme deficiency, affecting approximately 400 million people world-wide. It manifests as red blood cell (RBC) destruction in response to oxidative stress, which can be precipitated by infection, and by the ingestion of certain medications and foods. The prevalence of G6PD deficiency varies among populations and is most commonly found in individuals from sub-Saharan Africa, the Mediterranean region, and south-east Asia. Although in most studies G6PD-deficient individuals have normal RBC survival at steady-state, this may vary based upon the G6PD variant present, and some individuals may have shortened RBC survival. While it is not routine practice to screen blood donors for G6PD deficiency, G6PD deficient donor RBCs may store more poorly than normal RBCs. In addition, the transfusion of stored G6PD-deficient RBCs may result in decreased RBC survival after transfusion compared to RBCs from normal donors. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04081272
Study type Observational
Source Columbia University
Contact
Status Completed
Phase
Start date November 2012
Completion date October 2017

See also
  Status Clinical Trial Phase
Active, not recruiting NCT05096702 - Operational Feasibility of Appropriate Radical Cure of Plasmodium Vivax With Tafenoquine or Primaquine After Quantitative G6PD Testing in Brazil
Recruiting NCT04073953 - Primaquine Enantiomers in G6PD Deficient Human Volunteers Phase 1
Completed NCT02434952 - Safety and Tolerability of Low Dose Primaquine Phase 4
Enrolling by invitation NCT03655223 - Early Check: Expanded Screening in Newborns
Completed NCT04146246 - Comparative Evaluation of the FINDER Instrument and FINDER G6PD Cartridge in Adults and Neonates
Recruiting NCT05026489 - G6PD Deficiency in Infarction Patients in Shaanxi Province
Terminated NCT03337152 - Assessing a Risk Model for G6PD Deficiency Phase 4
Completed NCT05753150 - Operational Feasibility of Appropriate Plasmodium Vivax Radical Cure After G6PD Testing in Thailand
Completed NCT04010695 - Validation of Diagnostics to Identify Glucose-6-phosphate Dehydrogenase Activity in the US N/A
Completed NCT04033640 - Evaluation of a Diagnostic to Identify Glucose-6-phosphate Dehydrogenase (G6PD) Deficiency in Brazil N/A
Completed NCT01931644 - At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Active, not recruiting NCT03529396 - Safety and Efficacy of Different Regimens of Primaquine on Vivax Malaria Treatment in G6PD Deficient Patients Phase 2
Recruiting NCT05874271 - Short Course Primaquine for the Radical Cure of P. Vivax - Papua New Guinea N/A
Recruiting NCT04088513 - Safety and Efficacy of Aspirin in Stroke Patients With Glucose-6-phosphate Dehydrogenase Deficiency (SAST) Phase 4
Not yet recruiting NCT05571748 - Oxidative Stress, Carbohydrate Metabolism Disorders and G6PD Deficiency N/A
Not yet recruiting NCT02937376 - Effects of N-acetyl Cystein (NAC) Supplementation in G6PD Deficient Individuals After Acute Exercise Early Phase 1
Completed NCT02937363 - Effects of Alpha Lipoic Acid Supplementation in G6PD Deficient Individuals After Acute Exercise N/A
Recruiting NCT05879224 - Short Course Primaquine for the Radical Cure of P. Vivax Malaria - Indonesia N/A
Completed NCT04054661 - Validation of a Diagnostic Test for Glucose-6-phosphate Dehydrogenase (G6PD) Deficiency in Anti-coagulated Blood N/A